Ascendis Pharma
ASND
#1252
Rank
ยฃ13.68 B
Marketcap
ยฃ208.62
Share price
3.12%
Change (1 day)
26.85%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): ยฃ10.34

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is ยฃ10.35. In 2025 the company made an earnings per share (EPS) of -ยฃ3.24 an increase over its 2024 EPS that were of -ยฃ5.39.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ10.34-418.51%
2025-ยฃ3.24-39.79%
2024-ยฃ5.39-23.17%
2023-ยฃ7.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
-ยฃ0.12-101.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-ยฃ3.96-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
-ยฃ7.34-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA